Intersect ENT
XENT
#6022
Rank
HK$7.42 B
Marketcap
HK$219.71
Share price
0.00%
Change (1 day)
17.72%
Change (1 year)

Revenue for Intersect ENT (XENT)

Revenue in 2021: HK$0.83 Billion

According to Intersect ENT's latest financial reports the company's current revenue (TTM ) is HK$0.83 Billion. In 2021 the company made a revenue of HK$0.83 Billion an increase over the revenue in the year 2020 that were of HK$0.62 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Intersect ENT from 2012 to 2021

Annual revenue

Year Revenue Change
2021HK$0.83 B32.52%
2020HK$0.62 B-26.19%
2019HK$0.84 B0.62%
2018HK$0.84 B12.64%
2017HK$0.74 B22.35%
2016HK$0.61 B27.79%
2015HK$0.47 B59.62%
2014HK$0.30 B115.2%
2013HK$0.13 B205.83%
2012HK$45.61 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Ocular Therapeutix
OCUL
HK$0.43 B-47.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Anika Therapeutics
ANIK
HK$0.62 B-24.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Haemonetics
HAE
HK$10.33 B 1,143.91%๐Ÿ‡บ๐Ÿ‡ธ USA
ICON plc
ICLR
HK$63.03 B 7,490.40%๐Ÿ‡ฎ๐Ÿ‡ช Ireland